ahead volum asp guid line
ep exce consensu algn ep
beat forecast stronger revenu off-set weaker profit
factor line ad ep move
lower profit associ step invest nt intenational
reorg legal expens well higher tax rate
tp move lower view
reiter outperform admittedli clean report
unforeseen expens weigh consider nt profit
make meaning chang volum asp assumpt initi
guidanc encouragingli allud profit trend back line lt
target op margin nt invest includ new sale rep
na emea legal fee new corpor reorgan
initi better support growth multi-n compani
eye remain potenti volum upsid associ aforement
initi competit launch news inevit contribut headlin
risk view sustain double-digit trajectori impress low
revenu growth estimate double-digit ep growth despit asp
increment invest algn share pull back sinc
ep report vs ev/ebitda
share trade discount implant leader straumann
view unwarr risk includ competit econom malais
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
manufactur system clear align
therapi intra-or scanner cad/cam digit servic use
dentistri orthodont dental record storag
price jan rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
top-line healthystrong volume profit lag revenu growth
ahead plan strength case volum vs estimate drop
asp estimate better expect includ headwind fx mix shift
deterior us asp estimate elus teen segment line
america ortho volume slow latam broader remain
strong itero bright spot estimate key lead indic
oper margin fell bp promot mix invest bp plan
flow million fund million capit expenditur remain
debt free million cash reserv
overal thesi remain improv clinic awar consum sentiment
new technolog enhanc expand geograph teen market focu
drive continu double-digit revenu growth lt improv profit thereon
albeit time scalabl cost base outstand debt enhanc
visibl long-term double-digit ep growth encourag algn
commit grow address market via innov said materi
weaker expect nt margin profil focu area investor tomorrow
point step invest legal fee near term importantli make
chang volum asp assumpt exit
vastli better profit run rate higher previou assumpt
term quarter still make consider stride across under-penetrated
teen market help increasingli target advertis effort teen case start
strong y/i heel y/i growth ninth
consecut quarter teen volum grew faster adult
estim million orthodont case start year algn clear align
solut invisalign treat vs total case start driven
recent launch mandibular advanc offer us among innov
product launch past coupl year view algn on-going innov
continu distanc competitor deemphas impact recent
figur clear align case shipment patient type volum
train impress new invisalign doctor vs
includ north latin america help
sustain case growth momentum date boast doctor train world-wide
figur doctor train geograph segment
remain key sourc growth ou clear align revenu rise
repres algn case shipment
major algn doctor-add also outsid north america note
continu realiz higher averag sell price oversea intern
vs world-wide averag intern inher key growth area focu
unveil quarterli ep guidanc midpoint well
consensu predic revenu growth reflect significantli higher
oper expens due new sale rep add corp reorgan legal fee
higher tax rate along previous mention call commentari sustain
pressur associ aforement promot fx mix also
note expect revenu growth middl lt oper target rang
vs rang
moreov expect flat reflect growth intern
region increas share teen segment uptak non-comprehens product
well invisalign volum middl lt growth rang manag
expect gross margin improv cours year like approach lt
rang relat oper margin expect within
lt model second half includ impact
increas legal fee plan corpor structur organ also
expect equiti loss smd million per quarter tax rate
capital-expenditure
investor may admittedli somewhat disappoint absenc
meaning acceler volum associ sale forc mix shift promot
activ view may element conservat embed initi
guidanc note ttm dso deterior sequenti day day
though expect improv come quarter
acknowledg competitor clearli wing remain well ahead
term innov evidenc recent new product announc invisalign first
nex gen itero invisalign go mild-to-moder case expand
forecast revenu grow billion increas case
shipment ebitda margin expand bp y/i continu invest
go-to-market strategi off-set lower sg overal ep rise
well major hct peer
forecast revenu rise billion driven increas
case shipment estim ebitda margin expand bp y/i ep
increas ev/ebitda share close
discount lead dental implant manufactur straumann view
warrant light algn continu abil exceed higher expect
excel innov increasingli effect market strategi
full-scal clear align system exclus launch australia combin ormco market-lead
expertis digit treatment plan aesthet orthodong treatment expect build upon
earli traction expand offer go forward recent approv us
provid orthodontist flexibl treatment plan align bracket wire along
access oral portal intuit web-bas tool treatment plan oral portal
compat sever market intraor scanner
full arch clear align solut includ plan softwar allow clinician flexibl choos
optim treatment plan patient creat solut use either bracket wire
clear align focus broaden platform ad term digit
sagitt first/mot system use combin approach slx system
also use stand-alon clear align solut clinician submit digit impress
intraor scanner web portal treatment plan rang simpl aesthet
problem extens plan
clearcorrect solut typic use treat minor medium malocclus gross margin
acquisit typic use given limit treatment rang seen
recent orthodontist convers current focus america prepar full-market releas
europ latin america apac region
fast simpl align system minor intermedi anterior crowd space
five sequenti tray dual- single-arch case
leader clear align technolog new product releas includ invisalign first vivera
retain precis bite ramp invisalign go expand market reach
compani mention price
